Anatomical and pathophysiological classification of congenital heart disease

Gaetano Thiene1, Carla Frescura

  • 1Department of Medico-Diagnostic Sciences and Special Therapies, University of Padua Medical School, Padua, Italy. gaetano.thiene@unipd.it

Insights

Congenital heart diseases (CHD) are cardiac defects affecting blood flow. This study proposes a new classification based on how these defects impact circulation physiology for surgical planning.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Medical Classification Systems

Background:

  • Congenital heart diseases (CHD) involve structural cardiac defects impacting normal blood flow.
  • Understanding normal cardiac architecture and circulation is crucial for surgical repair.
  • Existing classifications may not fully capture the physiological consequences of CHD.

Purpose of the Study:

  • To propose a novel pathophysiological classification of congenital heart diseases.
  • To categorize CHD based on their clinical impact on blood circulation physiology.
  • To aid in surgical repair planning by understanding the sequence of cardiac segments.

Main Methods:

  • Developing a classification system for CHD based on physiological consequences.
  • Categorizing anomalies into five groups based on pulmonary blood flow and shunting.
  • Analyzing the impact of structural defects on venous drainage, septation, and valve function.

Main Results:

  • Proposed classification includes: 1) increased pulmonary blood flow, 2) decreased pulmonary flow, 3) obstruction without septal defects, 4) severe defects incompatible with postnatal life, and 5) asymptomatic adult-onset CHD.
  • This framework links structural defects to specific physiological outcomes.
  • The classification emphasizes the sequence of cardiac segments for surgical considerations.

Conclusions:

  • A pathophysiological classification of CHD offers a clinically relevant framework.
  • This approach facilitates surgical planning by clarifying the impact on blood circulation.
  • Understanding the physiological consequences of cardiac defects is key to managing CHD.

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...